Summit Therapeutics (SUMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

167.50p
   
  • Change Today:
    -2.50p
  • 52 Week High: 242.50
  • 52 Week Low: 142.50
  • Currency: UK Pounds
  • Shares Issued: 70.63m
  • Volume: 9,333
  • Market Cap: 118.30m
  • RiskGrade: 308

SUMM Overview

Summit Therapeutics is in the pharma and biotech sector and is currently trading at 167.50p per share. In the last year Summit Therapeutics 's share price has ranged from 142.50p to 242.50p.

1 Day Chart (17-11-2017)

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1080.4% n/a
ROCE 2360.9%  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 51.4 n/a
Pr/Book n/a  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

SUMM Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Jan-13 1.81 (4.57) (26.80)p n/a n/a n/a n/a 0.0%
31-Jan-14 1.38 (6.70) (30.00)p n/a n/a n/a n/a 0.0%
31-Jan-15 1.17 (12.66) (29.00)p n/a n/a n/a n/a 0.0%
31-Jan-16 n/a (23.20) (34.00)p n/a n/a n/a n/a 0.0%
31-Jan-17 2.30 (25.71) (35.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SUMM Company Announcements

Summit Therapeutics plc : Miscellaneous 16-Nov-2017 07:00 GlobeNewswire EU
Summit Highlights Utrophin Modulation as a Poten... 09-Nov-2017 12:00 GlobeNewswire EU
Summit Therapeutics Announces Revenue Sharing Ag... 06-Nov-2017 12:00 GlobeNewswire EU

Latest SUMM Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

SUMM Market Data

Currency UK Pounds
Share Price 167.50p
Change Today -2.50p
% Change -1.47 %
52 Week High 242.50
52 Week Low 142.50
Volume 9,333
Shares Issued 70.63m
Market Cap 118.30m
RiskGrade 308

SUMM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
4.54% above the market average4.54% above the market average4.54% above the market average4.54% above the market average4.54% above the market average
32.26% below the sector average32.26% below the sector average32.26% below the sector average32.26% below the sector average32.26% below the sector average
Price Trend
16.22% below the market average16.22% below the market average16.22% below the market average16.22% below the market average16.22% below the market average
26.15% above the sector average26.15% above the sector average26.15% above the sector average26.15% above the sector average26.15% above the sector average
Income Not Available
Growth Not Available

SUMM Dividends

No dividends found

Trades for 17-Nov-2017

Time Volume / Share Price
15:04 250 @ 165.23p
15:04 250 @ 165.23p
14:49 1,000 @ 165.10p
14:49 1,000 @ 165.10p
13:01 2,500 @ 166.25p

SUMM Key Personnel

CEO Glyn Edwards
COO David Roblin

Top of Page